Doctor's Bio
Dr. Tari King, MD, is a breast cancer surgeon with more than 20 years of experience caring for patients with breast cancer and other breast conditions. She specializes in breast cancer surgery and works with other cancer specialists to develop personalized treatment plans for each patient.
In addition to caring for patients, Dr. King is a nationally recognized breast cancer researcher. Her work focuses on breast cancer prevention, understanding how breast cancer develops and progresses, and finding better ways to combine surgery with other cancer treatments. She has contributed to clinical trials and research that have helped inform breast cancer treatment.
Before joining Emory, Dr. King held leadership positions at Memorial Sloan Kettering Cancer Center, Harvard Medical School, Brigham and Women’s Hospital, and Dana-Farber Brigham Cancer Center.
Board Certifications
American Board of Surgery
Affiliations
Emory
Education & Training
- Medical School: University of Colorado Health Sciences Center
- Internship: Ochsner Medical Institution
- Residency: Ochsner Medical Institutions
Fellowships
Memorial Sloan Kettering Cancer Center (MSKCC)
Locations and Directions
Correll Pavilion
Monday - Friday: 6 a.m. - 5:30 p.m.
Saturday: 7:30 a.m. - 3:30 p.m.
Publications
- Active Surveillance for Atypical Ductal Hyperplasia: Are We Ready for Surgical De-escalation?
Laws A, King TA
Cancer prevention research (Philadelphia, Pa.). 2026;19(10):555-557.
PMID: 42817619 - Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.
Tarantino P, Li T, Paré Brunet L, Sanfeliu E, Koca B, Guo R, Ollé-Monge M, Martínez-Sáez O, Cunningham O, Hughes ME, Patel A, King TA, Mittendorf EA, Lin NU, Brasó-Maristany F, Villacampa G, Villagrasa P, Tayob N, Prat A, Tolaney SM
European journal of cancer (Oxford, England : 1990). 2026;
PMID: 42710277 - Caring for Young Adults with Breast Cancer: Providers' Perspectives on Burnout in a Complex Care Landscape.
Lommer C, Schroeder L, Amato C, Kenny K, Sova L, Scheck McAlearney A, King TA, Davenport AP, Myers SP
Journal of adolescent and young adult oncology. 2026;
PMID: 42683556 - American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ.
Nakhlis F, Bedrosian I, King TA, Heller SL, Allison KH, Boolbol S, Pass HA, Johnson NM, Boughey JC, Yao K
JAMA surgery. 2026;
PMID: 42616513 - Association between self-reported breast cancer knowledge and clinical trial participation in patients with triple-negative breast cancer.
Tesch ME, Graham N, Snow C, Stever CE, Parker TS, Luo M, Martino IG, Drummey B, Virani S, Santos K, Bsat J, Ryan S, Hughes ME, Wrabel E, Tung N, Lo S, Ahmad N, Faggen M, Sinclair N, Constantinou M, Sinclair S, Meisel JL, King TA, Mittendorf EA, Tayob N, Lin NU, Partridge AH, Winer EP, Tolaney SM, Garrido-Castro AC
Breast cancer research and treatment. 2026;
PMID: 42530769 - ASO Visual Abstract: Artificial-Intelligence-Generated Electronic Medical Record Summarization in Breast Surgical Oncology.
Park KU, Sather BK, Shah A, Minami CA, Butler M, Butler L, Love JA, McLean K, Dunn A, Mittendorf EA, King TA
Annals of surgical oncology. 2026;33(10):9176-9177.
PMID: 42493710 - Artificial Intelligence-Generated Electronic Medical Record Summarization in Breast Surgical Oncology.
Park KU, Sather BK, Shah A, Minami CA, Butler M, Butler L, Love JA, McLean K, Dunn A, Mittendorf EA, King TA
Annals of surgical oncology. 2026;33(10):9102-9109.
PMID: 42455485 - Worsening frailty and declining quality of life in older survivors of non-metastatic breast cancer.
Minami CA, Jager LR, Lorentzen EH, Shadyab AH, Krok-Schoen JL, Nazmus Saquib AT, King JJ, Anderson GL, King TA, Mittendorf EA
Journal of the National Cancer Institute. 2026;
PMID: 42402217 - Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.
Crew KD, Anderson GL, Arnold KB, Dzingle S, Michel A, DeLucie M, Law CW, Pruthi S, Sandoval Leon AC, Shirley R, Grosse Perdekamp MT, Colonna SV, Krisher SL, King TA, Yee LD, Ballinger TJ, Braun-Inglis C, Mangino DA, Wisinski KB, DeYoung CA, Ross M, Floyd JD, Kaster A, VanderWalde LH, Saphner TJ, Zarwan C, Lo S, Graham C, Conlin AK, Yost Butler K, Agnese DM, Jernigan C, Hershman DL, Neuhouser ML, Zell JA, Arun B, Kukafka R
Journal of the National Cancer Institute. 2026;
PMID: 42391096 - Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe Trial.
Tarantino P, Li T, Ogayo ER, Rahman T, DiLullo MK, Patel A, El-Refai S, Abbott C, Li B, Boyle SM, Chen RO, Desai NV, Spring LM, Tung NM, Sinclair N, Faggen M, Constantine M, King TA, Krop IE, Tayob N, Mittendorf EA, Tolaney SM, Winer EP, Parsons HA, Waks AG
JAMA oncology. 2026;12(8):868-874.
PMID: 42348190
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.